salvin has been researched along with Leukemia, Myeloid, Acute in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Danilenko, M; Harrison, JS; Nachliely, M; Studzinski, GP; Wang, X | 1 |
| Danilenko, M; Dawod, A; Harrison, JS; Nachliely, M; Studzinski, GP; Wang, X | 1 |
| Harrison, JS; Studzinski, GP; Wang, X | 2 |
| Danilenko, M; Kutner, A; Nachliely, M; Sharony, E | 1 |
| Aqaqe, N; Barvish, Z; Danilenko, M; Fishman, D; Nachliely, M; Pesakhov, S; Schwartzman, B; Sharoni, Y; Studzinski, GP; Voronov, E | 1 |
| Bolla, NR; Danilenko, M; Kutner, A; Nachliely, M; Sharony, E | 1 |
| Amichay, D; Barvish, Z; Danilenko, M; Kafka, M; Levy, J; Shabtay, A; Sharabani, H; Sharoni, Y; Studzinski, GP; Uskokovic, MR | 1 |
| Chen-Deutsch, X; Garay, E; Harrison, JS; Studzinski, GP; Zhang, J | 1 |
| Danilenko, M; Studzinski, GP; Thompson, T; Vassilev, L | 1 |
| Danilenko, M; Khanin, M; Pesakhov, S; Studzinski, GP | 1 |
| Bobilev, I; Danilenko, M; Levi, I; Levy, J; Novik, V; Sharoni, Y; Shpilberg, O; Studzinski, GP | 1 |
| Chen-Deutsch, X; Studzinski, GP | 1 |
| Chen, XL; Cong, WH; Guo, G; Li, H; Li, XX; Wang, R; Yu, XN | 1 |
14 other study(ies) available for salvin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen.
Topics: Abietanes; Antineoplastic Agents; Antioxidants; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cytarabine; Ergocalciferols; Humans; Leukemia, Myeloid, Acute; MAP Kinase Kinase Kinase 5; Mitogen-Activated Protein Kinase 8; Signal Transduction; Vitamins | 2019 |
Differentiation agents increase the potential AraC therapy of AML by reactivating cell death pathways without enhancing ROS generation.
Topics: Abietanes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cytarabine; Ergocalciferols; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Reactive Oxygen Species; Receptors, Calcitriol; RNA Interference; RNA, Small Interfering; U937 Cells; Vitamin D | 2020 |
Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Topics: Abietanes; Annexin A5; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Differentiation; Comet Assay; Cytarabine; DNA Damage; Ergocalciferols; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Phosphorylation; Propidium; U937 Cells | 2016 |
Novel analogs of 1,25-dihydroxyvitamin D
Topics: Abietanes; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Ergocalciferols; Genes, Reporter; Humans; Leukemia, Myeloid, Acute; Point Mutation; Polyphenols; Receptors, Calcitriol; Transcriptional Activation | 2016 |
Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid.
Topics: Abietanes; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Calcium; Calcium Signaling; Caspases; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; HL-60 Cells; Homeostasis; Humans; Leukemia, Myeloid, Acute; Mice, Inbred C57BL; Mice, SCID; Time Factors; U937 Cells; Xenograft Model Antitumor Assays | 2016 |
The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.
Topics: Abietanes; Adult; Aged; Aged, 80 and over; Apoptosis; Bcl-2-Like Protein 11; Cytarabine; Drug Synergism; Ergocalciferols; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Receptors, Calcitriol; RNA Interference; Tumor Cells, Cultured; U937 Cells | 2016 |
Prodifferentiation Activity of Novel Vitamin D₂ Analogs PRI-1916 and PRI-1917 and Their Combinations with a Plant Polyphenol in Acute Myeloid Leukemia Cells.
Topics: Abietanes; Cell Differentiation; Cell Line, Tumor; Ergocalciferols; G1 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Plant Extracts; Polyphenols | 2016 |
Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.
Topics: Abietanes; Animals; Antioxidants; Bone Marrow; Calcitriol; Cell Differentiation; Cell Proliferation; Cholecalciferol; Disease Models, Animal; Drug Synergism; Humans; Immunoblotting; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Mice, Inbred BALB C; Plant Extracts; Reactive Oxygen Species; Rosmarinus; Survival Rate; Tumor Cells, Cultured | 2008 |
c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D.
Topics: Abietanes; Antioxidants; Cell Differentiation; Cell Division; Drug Resistance, Neoplasm; Enzyme Inhibitors; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 9; Plant Extracts; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-jun; Pyridines; RNA, Small Interfering; Transcription Factor AP-1; Tretinoin | 2009 |
Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants.
Topics: Abietanes; Antioxidants; Apoptosis; Blotting, Western; Calcitriol; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; G1 Phase; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Plant Extracts; Pyridines; Silybin; Silymarin; Tumor Suppressor Protein p53 | 2010 |
Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells.
Topics: Abietanes; Apoptosis; Caspases; Cell Proliferation; Curcumin; Drug Therapy, Combination; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Oligopeptides; Oxidative Stress; Plant Extracts; Silybin; Silymarin | 2010 |
The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells.
Topics: Abietanes; Calcitriol; Cell Differentiation; Glutamate-Cysteine Ligase; Glutathione; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Plant Extracts; Receptors, Calcitriol; Retinoid X Receptor alpha; Transcription Factor AP-1; Tumor Cells, Cultured; U937 Cells; Vitamin D Response Element | 2011 |
Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.
Topics: Abietanes; Amino Acid Chloromethyl Ketones; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid, Acute; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Protein Serine-Threonine Kinases; Pyridines; Quinolines; RNA Interference; RNA, Messenger; RNA, Small Interfering; U937 Cells; Vitamin D | 2012 |
Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway.
Topics: Abietanes; Apoptosis; Arsenic Trioxide; Arsenicals; Base Sequence; Blotting, Western; Cell Cycle; DNA Primers; Drug Synergism; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Oxides; Plant Extracts; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2012 |